Zhi-Lin Wang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Zhi-Lin Wang

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 18, 2015

[MicroRNA-10a expression in FAB different subtype of acute myeloid leukemia and its relationship with drug resistance]Yong-Jin Zhi, Feng Zhi, Rong Wang, et al.

Acta Pharmacologica Sinica|January 8, 2025

Compound 38, a novel potent and selective antagonist of adenosine A<sub>2A</sub> receptor, enhances arousal in miceHui Zhang, Wei-Xiang Ma, Qiong Xie, et al.

World Journal of Psychiatry|January 20, 2025

Comprehensive bibliometric analysis of pharmacotherapy for bipolar disorders: Present trends and future directionsBo-Fan Chen, Li Liu, Fang-Zhen Lin, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 18, 2015

[MicroRNA-10a expression in FAB different subtype of acute myeloid leukemia and its relationship with drug resistance]Yong-Jin Zhi, Feng Zhi, Rong Wang, et al.

Acta Pharmacologica Sinica|January 8, 2025

Compound 38, a novel potent and selective antagonist of adenosine A<sub>2A</sub> receptor, enhances arousal in miceHui Zhang, Wei-Xiang Ma, Qiong Xie, et al.

World Journal of Psychiatry|January 20, 2025

Comprehensive bibliometric analysis of pharmacotherapy for bipolar disorders: Present trends and future directionsBo-Fan Chen, Li Liu, Fang-Zhen Lin, et al.

Pageof 6